Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes

Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes - East Shizuoka Imeglimin study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060925

Enrollment

300

Registered

2026-04-01

Start date

2026-03-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes

Exclusion criteria

Exclusion criteria: Type 1 diabetes

Design outcomes

Primary

Measure	Time frame
Glycemic control(HbA1c)	—

Countries

Japan

Contacts

Public ContactTakashi Nomiyama

Juntendo university Shizuoka hospital Department of Diabetes, Endocrinology and Metabolism

nomiyama@juntendo.ac.jp08068120818

Outcome results